Yersinia pestis is the etiologic agent of pneumonic plague. Antibiotic-resistant strains of Y. pestis exist, and no licensed vaccine can prevent pneumonic plague. As such, intentionally aerosolized Y. pestis has the potential to cause a devastating pandemic. Subunit vaccines comprised of the Y.pestis F1 and/or V proteins provide mice and non-human primates with significant, but incomplete, protection against aerosolized plague. Neutralizing antibodies apparently play an important role in that protective response. CD4+T cells presumably contribute to protection as well, since they are critically important for memory B cell responses and the affinity maturation of antibodies. We hypothesize that, in addition to stimulating, maintaining, and/or boosting antibody responses, appropriately primed CD4+T cells can also direct cellular immunity at host cells harboring Y. pestis organisms. Relevant prior studies have been limited in scope, although they established that the F1 and V proteins do elicit significant CD4+T cell responses. Here, we propose to (i) determine the immunodominant epitopes recognized by V-specific CD4+T cells in C57BL/6 mice, (ii) develop sensitive assays for quantifying cytokine-producing V-specific T cells, (iii) optimize vaccination protocols to recruit V-specific CD4+T cells to inflamed pulmonary tissues, and (iv) decisively evaluate the capacities of vaccine-primed CD4+T cells to protect against pneumonic plague. Through these studies we will specifically test our hypothesis that vaccine-primed CD4+T cells can combat pneumonic plague via their capacities to stimulate cellular immunity. Subsequent experiments will decipher the precise underlying mechanisms, and strive to develop vaccination protocols that optimally elicit those activities. Acquiring direct information about the activation, expansion and persistence of Y. pestis-specific CD4+T cells in lung and lymphoid tissues, and optimizing vaccination strategies to harness the protective capacities of those cells, will undoubtedly aid the development of effective pneumonic plague vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI061577-02
Application #
6953138
Study Section
Special Emphasis Panel (ZRG1-IDM-A (90))
Program Officer
Schaefer, Michael R
Project Start
2004-09-30
Project End
2008-01-31
Budget Start
2005-02-01
Budget End
2006-01-31
Support Year
2
Fiscal Year
2005
Total Cost
$359,214
Indirect Cost
Name
Trudeau Institute, Inc.
Department
Type
DUNS #
020658969
City
Saranac Lake
State
NY
Country
United States
Zip Code
12983
Szaba, Frank M; Kummer, Lawrence W; Duso, Debra K et al. (2014) TNF? and IFN? but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection. PLoS Pathog 10:e1004142
Hickey, Anthony J; Lin, Jr-Shiuan; Kummer, Lawrence W et al. (2013) Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection. Infect Immun 81:2123-32
Luo, Deyan; Lin, Jr-Shiuan; Parent, Michelle A et al. (2013) Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis. J Immunol 190:4149-61
Zhang, Yue; Mena, Patricio; Romanov, Galina et al. (2012) A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis. Infect Immun 80:206-14
Luo, Deyan; Szaba, Frank M; Kummer, Lawrence W et al. (2011) Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica. J Immunol 187:1866-76
Lin, Jr-Shiuan; Szaba, Frank M; Kummer, Lawrence W et al. (2011) Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague. J Immunol 187:897-904
Lin, Jr-Shiuan; Kummer, Lawrence W; Szaba, Frank M et al. (2011) IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection. J Immunol 186:1675-84
Lin, Jr-Shiuan; Park, Steven; Adamovicz, Jeffrey J et al. (2010) TNF? and IFN? contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 29:357-62
Robinson, Richard T; Khader, Shabaana A; Martino, Cynthia A et al. (2010) Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration. J Exp Med 207:591-605
Szaba, Frank M; Kummer, Lawrence W; Wilhelm, Lindsey B et al. (2009) D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague. Infect Immun 77:4295-304

Showing the most recent 10 out of 20 publications